Health and Healthcare
1089 Articles
We recently gave a full review of the DJIA components we expect to raise their dividend payouts in the weeks…
AuthorDendreon Corporation (NASDAQ: DNDN) is supposed to be the king of prostate cancer with its PROVENGE treatment. Unfortunately, PROVENGE sales…
Dividends are still rising and equity and income investors should expect more of the same for 2012. The Walt Disney Company…
China’s factory activity reaches a 32-month low. (Reuters) Merck (NYSE: MRK) pays $950 million to settle Vioxx charges brought by…
Merck (NYSE: MRK) will pay $950 million to settle criminal and civil charges that it inappropriately promoted use of Vioxx, according…
It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1…
The economic choppiness is coming to a head with the age of dividend hikes. The pressure is going to remain…
Markets opened slightly lower this morning and spent the morning trying to decide on a direction. The Reuters/University of Michigan…
Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work…
A company can spend billions of dollars on R&D and get little respect as an innovator. Even though that is…
Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better…
Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent…
Angela Merkel faces a test: will her own party support money being used for the bailout of Greece? (Reuters) Bernanke…
The 30-Year Treasury auction, the so-called Long Bond, had a strong participation for what is technically a 29-year and 11-month…
Financial markets have been reeling as investors grow more concerned about the economy: An S&P downgrade of the full faith…
Our top personal finance-related articles today. Your wallet will thank you later.